Noninvasive radionuclide imaging of cardiac gene therapy: Progress and potential

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue SUPPL. 2, 2008, Pages

  Duyn, Jeff ^a   Koretsky, Alan P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; AMMONIA; BETA ACTIN; BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOSINE DEAMINASE; DOPAMINE 2 RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; INDIUM 111; IODINE 123; IODINE 131; LIPOSOME; MONOPHENOL MONOOXYGENASE; MYOSIN HEAVY CHAIN ALPHA; PERTECHNETIC ACID TC 99M; RECOMBINANT VASCULOTROPIN; SODIUM IODIDE SYMPORTER; SOMATOSTATIN RECEPTOR 2; TETRACYCLINE; THYMIDINE KINASE; TRANSFERRIN RECEPTOR; UNINDEXED DRUG; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN C; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENE ACTIVATION; GENE EXPRESSION SYSTEM; GENE INTERACTION; GENE PROBE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; ISCHEMIC HEART DISEASE; NON INVASIVE PROCEDURE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIRAL GENE DELIVERY SYSTEM;

GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HEART DISEASES; HUMANS; POSITRON-EMISSION TOMOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48349121580     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1113     Document Type: Article

References (32)

1. Henry TD et al. (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107 1359-1365
2. Grines CL et al. (2002) Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105: 1291-1297
3. Hedman M et al. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107: 2677-2683
4. Stewart DJ (2002) A phase 2, randomized multicenter, 26-week study to assess the efficacy and safety of BIOBYPASS (AdgvVEGF121.10) delivered through minimally invasive surgery versus maximum medical treatment in patients with severe angina, advanced coronary artery disease, and no options for revascularization [abstract]. Circulation 106: a2986
5. Simons M et al. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105: 788-793
6. ClinicalTrials.gov (online 15 January 2008) Angiogenesis in women with angina pectoris who are not candidates for revascularization (AWARE). [http://clinicaltrials.gov/show/NCT00438867]
7. CorautusGenetics (2006) Corautus announces termination of patient enrollment in GENASIS severe angina clinical trial. [http://www.corautus.com]
8. Kastrup J et al. (2005) Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: The Euroinject One trial. J Am Coll Cardiol 45: 982-988
9. Herschman HR (2003) Molecular imaging: Looking at problems, seeing solutions. Science 302: 605-608
10. Massoud TF and Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545-580
11. Gambhir SS et al. (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97: 2785-2790
12. Wu JC et al. (2004) Molecular imaging of cardiovascular gene products. J Nucl Cardiol 11: 491-505
13. Tjuvajev JG et al. (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res 56: 4087-4095
14. MacLaren DC et al. (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6: 785-791
15. Genove G et al. (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11: 450-454
16. Weissleder R et al. (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6: 351-355
17. Zinn KR et al. (2000) Noninvasive monitoring of gene transfer using a reporter receptor imaged with a highaffinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med 41: 887-895
18. Kaminsky SM et al. (1993) The Na+/I- symporter of the thyroid gland. Soc Gen Physiol Ser 48: 251-262
19. Miyagawa M et al. (2005) Cardiac reporter gene imaging using the human sodium/iodide symporter gene. Cardiovasc Res 65: 195-202
20. Miyagawa M et al. (2005) Non-invasive imaging of cardiac transgene expression with PET: Comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging 32: 1108-1114
21. Ponomarev V et al. (2007) A human-derived reporter gene for noninvasive imaging in humans: Mitochondrial thymidine kinase type 2. J Nucl Med 48: 819-826
22. Wu JC et al. (2002) Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106: 180-183
23. Bengel FM et al. (2003) Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108: 2127-2133
24. Porcel M et al.: Reporter gene imaging following percutaneous delivery in swine: Moving towards clinical applications. J Am Coll Cardiol, in press
25. Yla-Herttuala S et al. (2007) Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49: 1015-1026
26. 3-targeted magnetic resonance imaging. Nat Med 4: 623-626
27. Meoli DF et al. (2004) Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 113: 1684-1691
28. Wu JC et al. (2004) Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 110: 685-691
29. Dor Y et al. (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21: 1939-1947
30. Goverdhana S et al. (2005) Regulatable gene expression systems for gene therapy applications: Progress and future challenges. Mol Ther 12: 189-211
31. Heine HL et al. (2005) Strategies of conditional gene expression in myocardium: An overview. Methods Mol Med 112: 109-154
32. Chang GY et al. (2007) Positron emission tomography imaging of conditional gene activation in the heart. J Mol Cell Cardiol 43 18-26